KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Sales (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Return on Sales for 8 consecutive years, with 0.67% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 778.0% to 0.67% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.39% through Dec 2025, up 112.0% year-over-year, with the annual reading at 6.39% for FY2025, 65.0% up from the prior year.
  • Return on Sales hit 0.67% in Q4 2025 for Vir Biotechnology, up from 679.75% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1.07% in Q3 2021 to a low of 679.75% in Q3 2025.
  • Historically, Return on Sales has averaged 58.25% across 5 years, with a median of 4.57% in 2023.
  • Biggest five-year swings in Return on Sales: surged 8590bps in 2022 and later plummeted -58996bps in 2025.
  • Year by year, Return on Sales stood at 0.65% in 2021, then plummeted by -418bps to 2.06% in 2022, then tumbled by -236bps to 6.91% in 2023, then dropped by -22bps to 8.45% in 2024, then soared by 92bps to 0.67% in 2025.
  • Business Quant data shows Return on Sales for VIR at 0.67% in Q4 2025, 679.75% in Q3 2025, and 91.4% in Q2 2025.